To investigate safety and eficacy of yishumei--a injectable cross-linked sodium hyaluronate gel on alleviating moderate and severe nasolabial groove.
Methods A randomized,single-blind,parallel controlled study was conducted on selected volunteers with moderate and severe nasolabial groove.Restylane" ll or yishumei"(<1.5 ml)was injected either side to correct nasolabial groove.Bilateral nasolabial wrinkle severity rating scale (WSRS)and adverse events were evaluated by surgeon and volunteers independently at preoperative and immediately,4 weeks,12 weeks,24 weeks after procedure.SPSS13.0 software was used for statistical analysis.
Results The average age of 30 selected volunteers(28 female,2 male)was 45.8.Bilateral nasolabial WSRS declined after procedure,and the difference between
WSRS of immediately and of 24 weeks later has no statistically significance(P>0.05).Two cases of adverse events (2/30,6.67%)occurred during the test,and one case thought to be related to the research materials.
Reference From Journal of Practical Dermatology,Feb.2016 ,Vol.9,No.1
Writer:
ZHOU Zhi qiang,SUI Zhi fu,LIU Chang,et al
Institute of Skin Damage and Repair,GeneralHospital ofBeijing M ilitary Com mand,Beijing 100700,China
-
singclean | 2017-08-17
Singclean Medical to Debut Singderm® at IMCAS China 2026 – A PreviewShanghai, August 2026 – The 5th IMCAS China Congress is set to open on August 27–29, 2026 at the W Shanghai – The Bund. As one of the most anticipated gatherings in medical aesthetics, the event will bring together global experts, innovators, and clinicians. Among the featured exhibitors, Hangzhou Singclean Medical Products Co., Ltd. will make a strong impression by unveiling its premium hyaluronic acid filler Singderm® to the international community. -
singclean | 2017-08-17
Singclean to Showcase Comprehensive Healthcare Solutions at IMCAS China 2026, MEDITECH 2026 and MEDICAL FAIR ASIA 2026As part of its continued global expansion, Singclean Medical will participate in three major international healthcare exhibitions across Asia and Latin America in the second half of 2026: IMCAS China 2026 in Shanghai, MEDITECH 2026 in Bogotá, and MEDICAL FAIR ASIA 2026 in Singapore. These events provide valuable opportunities to connect with healthcare professionals, distributors, and industry partners while presenting Singclean's latest innovations in biomaterials and medical technology. -
singclean | 2017-08-17
Singclean Medical to Showcase Innovative Healthcare Solutions at WHX Bangkok 2026 and Meditech Colombia 2026Hangzhou, China | July 2026 Singclean Medical will participate in two leading international healthcare exhibitions this July—WHX Bangkok 2026 in Thailand and Meditech Colombia 2026 in Colombia—continuing its commitment to expanding its global presence and strengthening partnerships across Southeast Asia and Latin America.